Voyageur Pharmaceuticals Ltd. News
-
Voyageur Pharmaceuticals Launches U.S. Iodine Feasibility Study to Establish First Fully Integrated North American Contrast Drug Manufacturing Platform
August 25, 2025 (Source) — Voyageur Pharmaceuticals Ltd. (TSX.V: VM) (OTC: VYYRF) (“Voyageur” or the “Corporation”) is pleased…
-
Voyageur Pharmaceuticals Initiates First Commercial Shipments of Barium Contrast Products to Canadian Clinics
August 21, 2025 (Source) — TheNewswire – Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (OTC Pink:VYYRF) (“Voyageur” or the “Company”), a radiology…
-
Voyageur Pharmaceuticals Announces Exercise of Warrants for Gross Proceeds of $1.69 Million
August 19, 2025 (Source) — Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (OTC Pink:VYYRF) (“Voyageur” or the “Company”), a company with…
-
Voyageur Advances Frances Creek Barite Project with VAST Engagement for Bulk Sample Permit
August 18, 2025 (Source) — Voyageur Pharmaceuticals Ltd. (TSX.V: VM) (OTC: VYYRF) (“Voyageur” or the “Corporation”), is pleased to…
-
Voyageur Pharmaceuticals Grants Deferred Share Units and Options and Accelerates Expiry Date of Warrants
July 14, 2025 (Source) — Voyageur Pharmaceuticals Ltd. (TSX.V: VM) (OTC: VYYRF) (“Voyageur” or the “Corporation”), a provider…
-
Voyageur Pharmaceuticals Signs LOI for Latin America Distribution Partnership Supporting Global Market Expansion
June 24, 2025 (Source) — Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (OTC Pink:VYYRF) (“Voyageur”, or the “Company”), a Canadian public company…
-
Voyageur and Altillion Forge Landmark Alliance to Establish North America’s First Vertically Integrated Iodine Drug Supply Chain
June 23, 2025 (Source) — Voyageur Pharmaceuticals Ltd. (TSXV:VM) (“Voyageur” or the “Company”), a Canadian public company developing cost-effective…
-
Voyageur Enters Revenue Stage with First Commercial Sale of Barium Contrast Agents
June 4, 2025 (Source) — Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (OTC Pink:VYYRF) (“Voyageur” or the “Company”), a radiology contrast…
-
Voyageur Pharmaceuticals Announces Appointment of Ethan Mohan as Executive Vice President
May 12, 2025 (Source) — Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (OTC Pink:VYYRF) (“Voyageur” or the “Company”) a radiology contrast…
-
Voyageur Pharmaceuticals Announces Changes to Board of Directors and DSU Grant
Ralph Hesje Retires as Chairman Eric Pommer Assumes Role of Chairperson Beth Shaw Appointed to Board May 1,…
